Selected research
Industry Research
Niraparib API Industry Research Report 2026
Market perspective
The global Niraparib API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Niraparib API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Niraparib API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Niraparib API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Niraparib API include Nantong Changyou Pharmaceutical Technology, Asymchem, WuXi STA, Valary Lab, SynZeal Research, Jigs chemical, Dr. Reddy's Laboratories and Bulat Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Niraparib API market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Niraparib API Market by Company
Nantong Changyou Pharmaceutical Technology
Asymchem
WuXi STA
Valary Lab
SynZeal Research
Jigs chemical
Dr. Reddy's Laboratories
Bulat Pharmaceutical
Niraparib API Segment by Type
0.98
0.99
Niraparib API Segment by Application
Tablets
Capsules
Other
Niraparib API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Niraparib API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Niraparib API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Niraparib API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Niraparib API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Niraparib API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Niraparib API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.98
- 0.99
Applications
- Tablets
- Capsules
- Other
Companies covered
- Nantong Changyou Pharmaceutical Technology
- Asymchem
- WuXi STA
- Valary Lab
- SynZeal Research
- Jigs chemical
- Dr. Reddy's Laboratories
- Bulat Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Niraparib API Market Size (2021-2032)
- 2.2.2 Global Niraparib API Sales (2021-2032)
- 2.2.3 Global Niraparib API Market Average Price (2021-2032)
- 2.3 Niraparib API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0.98
- 2.3.3 0.99
- 2.4 Niraparib API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Tablets
- 2.4.3 Capsules
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Niraparib API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Niraparib API Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Niraparib API Revenue of Manufacturers (2021-2026)
- 3.4 Global Niraparib API Average Price by Manufacturers (2021-2026)
- 3.5 Global Niraparib API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Niraparib API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Niraparib API, Product Type & Application
- 3.8 Global Manufacturers of Niraparib API, Established Date
- 3.9 Global Niraparib API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Nantong Changyou Pharmaceutical Technology
- 4.1.1 Nantong Changyou Pharmaceutical Technology Company Information
- 4.1.2 Nantong Changyou Pharmaceutical Technology Business Overview
- 4.1.3 Nantong Changyou Pharmaceutical Technology Niraparib API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Nantong Changyou Pharmaceutical Technology Niraparib API Product Portfolio
- 4.1.5 Nantong Changyou Pharmaceutical Technology Recent Developments
- 4.2 Asymchem
- 4.2.1 Asymchem Company Information
- 4.2.2 Asymchem Business Overview
- 4.2.3 Asymchem Niraparib API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Asymchem Niraparib API Product Portfolio
- 4.2.5 Asymchem Recent Developments
- 4.3 WuXi STA
- 4.3.1 WuXi STA Company Information
- 4.3.2 WuXi STA Business Overview
- 4.3.3 WuXi STA Niraparib API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 WuXi STA Niraparib API Product Portfolio
- 4.3.5 WuXi STA Recent Developments
- 4.4 Valary Lab
- 4.4.1 Valary Lab Company Information
- 4.4.2 Valary Lab Business Overview
- 4.4.3 Valary Lab Niraparib API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Valary Lab Niraparib API Product Portfolio
- 4.4.5 Valary Lab Recent Developments
- 4.5 SynZeal Research
- 4.5.1 SynZeal Research Company Information
- 4.5.2 SynZeal Research Business Overview
- 4.5.3 SynZeal Research Niraparib API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 SynZeal Research Niraparib API Product Portfolio
- 4.5.5 SynZeal Research Recent Developments
- 4.6 Jigs chemical
- 4.6.1 Jigs chemical Company Information
- 4.6.2 Jigs chemical Business Overview
- 4.6.3 Jigs chemical Niraparib API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jigs chemical Niraparib API Product Portfolio
- 4.6.5 Jigs chemical Recent Developments
- 4.7 Dr. Reddy's Laboratories
- 4.7.1 Dr. Reddy's Laboratories Company Information
- 4.7.2 Dr. Reddy's Laboratories Business Overview
- 4.7.3 Dr. Reddy's Laboratories Niraparib API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Dr. Reddy's Laboratories Niraparib API Product Portfolio
- 4.7.5 Dr. Reddy's Laboratories Recent Developments
- 4.8 Bulat Pharmaceutical
- 4.8.1 Bulat Pharmaceutical Company Information
- 4.8.2 Bulat Pharmaceutical Business Overview
- 4.8.3 Bulat Pharmaceutical Niraparib API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bulat Pharmaceutical Niraparib API Product Portfolio
- 4.8.5 Bulat Pharmaceutical Recent Developments
5 Global Niraparib API Market Scenario by Region
- 5.1 Global Niraparib API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Niraparib API Sales by Region: 2021-2032
- 5.2.1 Global Niraparib API Sales by Region: 2021-2026
- 5.2.2 Global Niraparib API Sales by Region: 2027-2032
- 5.3 Global Niraparib API Revenue by Region: 2021-2032
- 5.3.1 Global Niraparib API Revenue by Region: 2021-2026
- 5.3.2 Global Niraparib API Revenue by Region: 2027-2032
- 5.4 North America Niraparib API Market Facts & Figures by Country
- 5.4.1 North America Niraparib API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Niraparib API Sales by Country (2021-2032)
- 5.4.3 North America Niraparib API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Niraparib API Market Facts & Figures by Country
- 5.5.1 Europe Niraparib API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Niraparib API Sales by Country (2021-2032)
- 5.5.3 Europe Niraparib API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Niraparib API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Niraparib API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Niraparib API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Niraparib API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Niraparib API Market Facts & Figures by Country
- 5.7.1 South America Niraparib API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Niraparib API Sales by Country (2021-2032)
- 5.7.3 South America Niraparib API Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Niraparib API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Niraparib API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Niraparib API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Niraparib API Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Niraparib API Sales by Type (2021-2032)
- 6.1.1 Global Niraparib API Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Niraparib API Sales Market Share by Type (2021-2032)
- 6.2 Global Niraparib API Revenue by Type (2021-2032)
- 6.2.1 Global Niraparib API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Niraparib API Revenue Market Share by Type (2021-2032)
- 6.3 Global Niraparib API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Niraparib API Sales by Application (2021-2032)
- 7.1.1 Global Niraparib API Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Niraparib API Sales Market Share by Application (2021-2032)
- 7.2 Global Niraparib API Revenue by Application (2021-2032)
- 7.2.1 Global Niraparib API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Niraparib API Revenue Market Share by Application (2021-2032)
- 7.3 Global Niraparib API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Niraparib API Value Chain Analysis
- 8.1.1 Niraparib API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Niraparib API Production Mode & Process
- 8.2 Niraparib API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Niraparib API Distributors
- 8.2.3 Niraparib API Customers
9 Global Niraparib API Analyzing Market Dynamics
- 9.1 Niraparib API Industry Trends
- 9.2 Niraparib API Industry Drivers
- 9.3 Niraparib API Industry Opportunities and Challenges
- 9.4 Niraparib API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst